Kaneka Corporation (KANKF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kaneka Corporation (KANKF) trades at $25.17 with AI Score 46/100 (Grade C). Kaneka Corporation is a globally diversified Japanese manufacturer with a broad portfolio spanning chemicals, advanced materials, healthcare, and food products. Market cap: $1.52B, Sector: Basic materials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for KANKF: KANKF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KANKF against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KANKF: the 1 perspectives are evenly split.
How is this calculated? →Kaneka Corporation (KANKF) Materials & Commodity Exposure
Kaneka Corporation, a Tokyo-based global manufacturer established in 1949, specializes in a diverse array of chemical and advanced materials, including PVC products, specialty polymers, and films. The company also operates in healthcare, life sciences, and food products, serving industrial, medical, and consumer markets with its broad portfolio.
What Is the Investment Thesis for KANKF?
Kaneka Corporation presents a unique investment profile characterized by its extensive diversification across specialty chemicals, advanced materials, healthcare, and food products, which potentially buffers against downturns in any single market. The company demonstrates operational efficiency with a gross margin of 27.6%, although its profit margin stands at 3.8%. With a market capitalization of $1.52B and a P/E ratio of 10.80, Kaneka may be viewed as a value opportunity relative to market averages. A notable dividend yield of 2.82% further enhances its appeal for income-focused investors. The company's low Beta of 0.32 suggests lower price volatility compared to the broader market. Key growth catalysts include the increasing global demand for renewable energy, driving its photovoltaic systems segment, and advancements in healthcare, particularly regenerative medicine and cell therapy solutions. Ongoing innovation in specialty polymers and functional foodstuffs also represents significant value drivers. However, investors must consider risks such as its exposure to global economic conditions and raw material price fluctuations, which can impact profitability. Furthermore, its OTC listing introduces liquidity risks compared to exchange-listed peers, warranting careful due diligence.
Based on FMP financials and quantitative analysis
KANKF Key Highlights
- Market capitalization of $1.52B, reflecting its scale as a diversified global manufacturer.
- Gross margin of 27.6%, indicating efficiency in its production processes across various segments.
- A P/E ratio of 10.80, suggesting a potentially undervalued position relative to broader market averages.
- Dividend yield of 2.82%, providing income to shareholders.
- A low Beta of 0.32, indicating lower volatility compared to the overall market.
Who Are KANKF's Competitors?
KANKF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
| ELKEF Elkem ASA | $3.40 | +0.00% | $2.16B | 50 |
| GVDBF Givaudan S.A. | $3440.15 | -18.91% | $31.75B | 50 |
| AVNT Avient Corporation | $38.83 | +4.07% | $3.56B | 50 |
| HWKN Hawkins, Inc. | $139.44 | +0.69% | $2.92B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KANKF's Key Strengths?
- Highly diversified product portfolio across chemicals, materials, healthcare, and food, mitigating sector-specific risks.
- Strong R&D capabilities evident in innovative products like biodegradable polymers and advanced films.
- Established global presence and manufacturing infrastructure supporting its diverse business segments.
- Solid gross margin of 27.6% demonstrating operational efficiency in its production processes.
What Are KANKF's Weaknesses?
- Exposure to raw material price fluctuations impacting profitability across its chemical and materials divisions.
- Liquidity risks associated with its OTC listing compared to exchange-listed peers.
- Profit margin of 3.8% indicates relatively thin net profitability despite strong gross margins.
- Unknown disclosure status on the OTC market, potentially limiting investor access to comprehensive financial information.
What Could Drive KANKF Stock Higher?
- Continued innovation in specialty polymers and advanced materials to meet evolving industrial demands across electronics, automotive, and construction sectors.
- Expansion of photovoltaic power generation system installations in residential, public, and industrial sectors, capitalizing on global renewable energy trends.
- Advancements and commercialization of new products within its healthcare and life sciences division, such as regenerative medicine solutions and advanced diagnostics.
- Introduction of new functional foodstuffs and nutritional supplements to address growing consumer health and wellness trends.
- Potential strategic partnerships or acquisitions aimed at expanding market reach or enhancing technological capabilities in key growth areas like sustainable materials or biopharmaceuticals.
What Are the Key Risks for KANKF?
- Fluctuations in raw material prices, particularly for chemicals and polymers, which can impact production costs and profit margins across its materials segments.
- Global economic downturns or regional slowdowns that could reduce demand across Kaneka's highly diversified industrial and consumer product segments.
- Liquidity risks associated with its OTC listing, potentially leading to wider bid-ask spreads and difficulty in executing trades.
- Increased competition from both established global players and emerging innovators across its various product categories, from specialty chemicals to medical devices.
- Adverse regulatory changes or stricter environmental standards impacting its chemical manufacturing processes or product approvals in its healthcare and food divisions.
What Are the Growth Opportunities for KANKF?
- Advanced Materials & Specialty Polymers: Kaneka's portfolio includes silyl-terminated polyether, high-performance engineering resins, and polyimide films, catering to industries like electronics, automotive, and construction that demand durability, heat resistance, and specific optical properties. The global specialty chemicals market is projected for sustained growth, driven by technological advancements and expanding application areas. Kaneka's long-standing research and development capabilities in materials science provide a competitive advantage in formulating customized solutions, allowing it to capture market share by addressing the evolving performance requirements of industrial clients worldwide.
- Photovoltaic Power Generation Systems: With increasing global emphasis on renewable energy, Kaneka's development of photovoltaic power generation systems for residential, public, and industrial installations represents a significant growth driver. The solar energy market is experiencing robust expansion due to environmental concerns, supportive government policies, and decreasing installation costs. Kaneka's integrated approach, from material science to system development, positions it to capitalize on this trend, especially with its focus on innovative, high-efficiency panel technologies that can differentiate its offerings in a competitive market and contribute to sustainable energy infrastructure.
- Healthcare and Life Sciences Solutions: The aging global population and continuous advancements in medical technology are fueling demand for medical products, diagnostics, and regenerative medicine. Kaneka's offerings in this segment include medical products for intervention, blood purification, and gastroenterology, alongside diagnostic testing equipment, regenerative medicine, and cell therapy solutions. The biopharmaceutical and medical device markets are characterized by ongoing innovation and high barriers to entry. Kaneka's deep expertise in materials science can lead to the development of novel medical devices and advanced drug delivery systems, providing a competitive edge in specialized, high-value niches within the critical healthcare sector.
- Functional Foodstuffs and Nutritional Products: Consumer trends increasingly lean towards health and wellness, driving demand for functional foods, dietary supplements, and specialized nutrition. Kaneka addresses this by providing coenzyme, lactic-acid bacteria, and other functional foodstuffs, alongside a wide range of dairy and processed food ingredients. The global functional food market is expanding as consumers actively seek products offering health benefits beyond basic nutrition. Kaneka's research and development in bioscience and food technology enables it to develop innovative ingredients and finished products that cater to these evolving dietary preferences, securing its position in a growing consumer market.
- Eco-friendly and Sustainable Materials: Growing environmental awareness and stringent regulatory pressures are accelerating the demand for sustainable alternatives across industries. Kaneka's portfolio includes biodegradable polymers, biosurfactants, and eco-friendly fur, aligning with global initiatives to reduce plastic waste and promote green manufacturing practices. The market for sustainable materials is projected for substantial growth, driven by corporate sustainability goals, consumer preference for environmentally responsible products, and regulatory mandates. Kaneka's commitment to developing and commercializing environmentally conscious materials provides a long-term growth avenue, enhances its brand reputation, and positions it favorably in the circular economy.
What Opportunities Does KANKF Have?
- Growing global demand for renewable energy solutions, particularly photovoltaic systems for various installations.
- Expansion into advanced healthcare and life sciences, including regenerative medicine and genetic diagnostics.
- Increasing consumer demand for functional foods and nutritional supplements driven by health and wellness trends.
- Development and commercialization of eco-friendly and sustainable materials to meet evolving market and regulatory demands.
What Threats Does KANKF Face?
- Intense competition across its diverse business segments from specialized and large-scale global manufacturers.
- Vulnerability to global economic downturns or regional slowdowns affecting demand for industrial materials and consumer products.
- Adverse regulatory changes or stricter environmental standards impacting its chemical manufacturing processes or product approvals.
- Currency exchange rate fluctuations given its global operations and headquarters in Japan, potentially affecting reported earnings.
What Are KANKF's Competitive Advantages?
- Extensive and highly diversified product portfolio across chemicals, materials, healthcare, and food, reducing reliance on any single market.
- Deep expertise in materials science and chemical synthesis, enabling the development of high-performance and specialized products.
- Established global manufacturing and distribution network supporting its diverse business segments.
- Ongoing research and development efforts leading to innovative products like biodegradable polymers, advanced films, and regenerative medicine solutions.
- Strong brand recognition and long-standing customer relationships in its core markets, built over decades since its founding in 1949.
What Does KANKF Do?
Kaneka Corporation, established in Tokyo, Japan, in 1949, functions as a globally diversified manufacturer with a rich history rooted in chemical innovation. Over decades, the company has evolved significantly, expanding its expertise beyond traditional chemicals into advanced materials, healthcare, and food products. Its extensive chemical and advanced materials portfolio includes a broad spectrum of polyvinyl chloride (PVC) products, such as crosslinked, paste, and chlorinated PVC, alongside PVC-PVAc polymers and acryl grafted-vinyl chloride copolymers. Kaneka also provides various chemical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins, catering to diverse industrial applications. Beyond basic chemicals, its specialized polymer offerings feature silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, high-performance engineering resins for injection molding, materials with zero birefringence, acrylic films, and isobutylene-based thermoplastic elastomers. The company manufactures an array of foams, including polypropylene, Kanelite, and extruded polystyrene insulation, crucial for construction and packaging. Its advanced film products encompass polyimide film, transparent films for optical applications, highly thermally conductive graphite sheets, multi-layer insulation, and transparent conductive films, in addition to thermo-resistant and light-resistant transparent resin products. In the energy and cutting-edge materials sector, Kaneka develops photovoltaic power generation systems for residential, public, and industrial installations, alongside innovative products like eco-friendly fur, flame-retardant substances, and biosurfactants. The corporation holds a significant presence in healthcare and life sciences, delivering medical products for intervention, blood purification, and gastroenterology, diagnostic testing equipment, regenerative medicine, cell therapy solutions, and genetic diagnostic products. Its pharmaceutical contributions include low molecular pharmaceutical materials, affinity chromatography resins, biopharmaceuticals, and transdermal medicines. Lastly, Kaneka offers a comprehensive selection of food and nutritional products, covering dairy items, margarines, fats and oils, baker's yeast, processed fruits, and specialized pharma and supplemental nutrition solutions such as coenzyme and lactic-acid bacteria, alongside agricultural fertilizers. This broad diversification allows Kaneka to serve a global customer base across multiple critical sectors.
What Products and Services Does KANKF Offer?
- Manufacture a wide range of polyvinyl chloride (PVC) products and chemical additives for various industrial applications.
- Develop and produce specialized polymers, including high-performance engineering resins and biodegradable materials.
- Produce various foams, such as polypropylene and extruded polystyrene insulation, used in construction and packaging.
- Create advanced film products like polyimide films and transparent optical films for electronics and displays.
- Design and install photovoltaic power generation systems for residential, public, and industrial use.
- Offer medical products for intervention, blood purification, and regenerative medicine, alongside diagnostic equipment.
- Produce pharmaceutical materials, biopharmaceuticals, and transdermal medicines.
- Supply a diverse array of food products, including dairy, margarines, baker's yeast, and functional foodstuffs like coenzyme Q10.
How Does KANKF Make Money?
- Selling a broad portfolio of chemical and advanced materials to industrial clients across construction, automotive, and electronics sectors.
- Generating revenue from the sale and installation of photovoltaic power generation systems for energy solutions.
- Developing, manufacturing, and distributing medical devices, diagnostic equipment, and pharmaceutical ingredients to healthcare providers and pharmaceutical companies.
- Producing and selling food ingredients, dairy products, and functional foodstuffs to food manufacturers, bakeries, and consumers.
- Licensing proprietary technologies and materials for specialized applications in various industries.
What Industry Does KANKF Operate In?
Kaneka Corporation operates primarily within the Basic Materials sector, specifically the Specialty Chemicals industry, but its extensive diversification places it at the intersection of several high-growth markets. In specialty chemicals, the company navigates a landscape driven by demand for high-performance materials in electronics, automotive, and construction, where innovation in polymers and additives is key. Beyond this, Kaneka's presence in healthcare and life sciences positions it within a rapidly expanding sector fueled by an aging global population and technological advancements in medical devices, diagnostics, and regenerative medicine. Its food and nutrition segment taps into consumer trends favoring functional foods and health supplements. This multi-sector approach allows Kaneka to leverage synergies across its R&D efforts and potentially mitigate risks associated with cyclicality in any single industry. The competitive landscape is fragmented, with Kaneka competing against specialized chemical companies, major pharmaceutical firms, and global food manufacturers depending on the specific product line.
Who Are KANKF's Key Customers?
- Industrial manufacturers requiring specialty chemicals, polymers, and advanced films for their production processes.
- Construction companies and developers utilizing Kaneka's foams and insulation materials.
- Energy sector clients, including residential, commercial, and industrial entities, for photovoltaic power generation systems.
- Healthcare institutions, hospitals, and pharmaceutical companies purchasing medical products, diagnostic tools, and drug components.
- Food and beverage manufacturers, bakeries, and direct consumers for dairy products, food ingredients, and nutritional supplements.
How Kaneka Corporation Is Valued
Kaneka Corporation carries a market capitalization of $1.52B, placing it in the small-cap category. Relative to its peer group, KANKF's quantitative score of 46/100 is below the peer average of 64/100.
Company Profile
Kaneka Corporation operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Tokyo, JP. The company is led by CEO Kazuhiko Fujii. KANKF has traded publicly since 2010.
ROE 6%Key Financial Metrics
Return on equity for Kaneka Corporation stands at 6.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.2%, showing how much profit it generates from its asset base. KANKF trades at a trailing price-to-earnings ratio of 11.12, below the Basic Materials sector average of ~22x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.53 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 9.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Kaneka Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.10 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Kaneka Corporation revenue of about $814.19B for fiscal 2026, with EPS near $480.26. The estimate reflects 6 contributing analysts.
KANKF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Highly diversified product portfolio across chemicals, materials, healthcare, and food, mitigating sector-specific risks.
- Strong R&D capabilities evident in innovative products like biodegradable polymers and advanced films.
- Established global presence and manufacturing infrastructure supporting its diverse business segments.
- Solid gross margin of 27.6% demonstrating operational efficiency in its production processes.
Bear Case
- Exposure to raw material price fluctuations impacting profitability across its chemical and materials divisions.
- Liquidity risks associated with its OTC listing compared to exchange-listed peers.
- Profit margin of 3.8% indicates relatively thin net profitability despite strong gross margins.
- Unknown disclosure status on the OTC market, potentially limiting investor access to comprehensive financial information.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
KANKF Latest News
No recent news available for KANKF.
KANKF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KANKF.
Price Targets
Wall Street price target analysis for KANKF.
KANKF MoonshotScore
What does this score mean?
The MoonshotScore rates KANKF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kazuhiko Fujii
CEO
Unknown
Track Record: Unknown
KANKF OTC Market Information
Kaneka Corporation trades on the OTC market under the 'OTC Other' tier. This classification is the lowest of the three primary OTC tiers (OTCQX, OTCQB, and OTC Pink, which includes 'Other'). Companies in the 'OTC Other' category typically have fewer stringent financial reporting and disclosure requirements compared to those on major exchanges like the NYSE or NASDAQ, or even higher OTC tiers. This tier may include companies with limited public information, distressed businesses, or those that do not meet the standards for OTCQX or OTCQB, implying a higher degree of risk and potentially less transparency for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity and wider bid-ask spreads compared to exchange-listed stocks, making trading more difficult.
- Increased price volatility due to lower trading volumes and limited market depth.
- Limited public financial information and disclosure, as the company's disclosure status is 'Unknown'.
- Less regulatory oversight compared to major exchanges, potentially increasing risks related to transparency and corporate governance.
- Higher potential for market manipulation or difficulty in obtaining reliable valuations due to less available data.
- Verify any available financial statements and annual reports directly from the company or reliable third-party sources.
- Research the company's business operations, product lines, and market position thoroughly, independent of public filings.
- Evaluate the management team's experience, track record, and corporate governance practices.
- Understand the specific market structure and trading dynamics of the OTC 'Other' tier.
- Consult with legal and financial advisors experienced in OTC markets before making investment decisions.
- Assess the company's competitive landscape and industry trends, considering the potential for limited public data.
- Monitor any news or press releases from the company for updates on its operations and financial health.
- Established company founded in 1949, indicating a long operational history.
- Globally diversified manufacturer with a broad portfolio across multiple sectors.
- Significant employee base of 11,544, suggesting substantial operations.
- Headquartered in Tokyo, Japan, a major global economic center.
What Investors Ask About Kaneka Corporation (KANKF) — Basic Materials
What is Kaneka Corporation's core business model and how diversified is it?
Kaneka Corporation operates a highly diversified business model, generating revenue across multiple distinct segments. Its core involves the manufacturing and sale of a vast array of chemical and advanced materials, including various PVC products, specialty polymers, foams, and advanced films, serving industrial applications. Beyond materials, Kaneka is significantly involved in energy, developing photovoltaic systems, and in healthcare, offering medical products, diagnostics, and regenerative medicine solutions. Furthermore, it has a substantial food and nutrition segment, producing dairy items, functional foodstuffs, and supplements. This broad diversification aims to mitigate risks associated with reliance on any single market or product line.
How does Kaneka Corporation manage its exposure to raw material price volatility, given its operations in basic materials?
As a major manufacturer in the Basic Materials sector, Kaneka Corporation is inherently exposed to fluctuations in raw material prices, which can impact its cost of goods sold and overall profitability. While the provided data does not detail specific hedging strategies, a key aspect of its risk management is its highly diversified product portfolio. By operating across numerous chemical, polymer, and material categories, as well as in healthcare and food, the company can potentially offset adverse impacts in one material market with more stable performance or pricing power in another. Monitoring global economic conditions and raw material price trends is crucial for assessing its ongoing profitability.
What are the implications of Kaneka Corporation being traded on the OTC market for investors?
Kaneka Corporation's listing on the OTC market, specifically in the 'OTC Other' tier, carries several implications for investors. This tier typically has fewer stringent financial reporting and disclosure requirements compared to major exchanges like NYSE or NASDAQ, and its disclosure status is currently 'Unknown.' This can lead to less readily available financial information, making comprehensive due diligence more challenging. Furthermore, OTC stocks generally experience lower trading volumes and wider bid-ask spreads, resulting in reduced liquidity. This means investors might find it more difficult to buy or sell shares quickly without significantly impacting the price, increasing transaction costs and price volatility compared to exchange-listed securities.
What are the key factors to evaluate for KANKF?
Kaneka Corporation (KANKF) holds an AI score of 46/100 (low). Not financial advice.
How frequently does KANKF data refresh on this page?
KANKF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KANKF's recent stock price performance?
Kaneka Corporation (KANKF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Highly diversified product portfolio across chemicals, materials, healthcare, and food, mitigating sector-specific risks. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KANKF overvalued or undervalued right now?
Valuing Kaneka Corporation (KANKF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying KANKF?
Before investing in Kaneka Corporation (KANKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information regarding CEO's title, background, track record, and tenure years was not provided in the source data.
- Specific competitor tickers were not provided.
- OTC disclosure status is unknown.